Skip to main content

Table 2 Patients’ characteristics

From: Electro-clinical and neurodevelopmental outcome in six children with early diagnosis of tuberous sclerosis complex and role of the genetic background

Patient

Gender

TSC Criteria at enrollment

Other MRI findings

Genetic testing

Age at first EEG

Result

Age at abn EEG (A)

Classification

Age at Sz onset (B)

Sz type

Time from A to B

GVG

Sz Relapse

EEG at f-up

EEG abn-N

Age at last f-up

Cognitive-behavioral phenotype

1

F

PsCT,CT,SENs

 

TSC2

4 m

N

8 m

c1

na

na

na

na

 

N

 

25 m

N

2

M

PsCT,HM,CT,SENs

 

NMI

6 m

N

na

N

10 m

CS (fever)

na

na

 

N

 

36 m

N

3

M

PCT,CT,SENs,RH

 

TSC2

3 m

N

4 m

c3

4 m

IS

0

4 m

 

N at 6 m

2 m

25 m

mild LD

4

F

PCT,CT,SENs

 

TSC2

2 m

N

4 m

d3

7 m

IS

3 m

7 m

 

N at 12 m

5 m

30 m

N

5

M

PsCT,CT,SENs

SEGA

TSC2

1 m

FD

1 m

d3

4 m

IS, (FS 8 m)

3 m

4 m

20 m

FD

 

52 m

ID; ASD

6

M

PCT,CT

MCD

TSC2

2 m

N

4 m

b2

4 m

FS, (IS 7 m)

0

4 m

5 m

FD

 

25 m

ID

  1. MRI magnetic resonance imaging, SZ seizure, PCT Prenatally found cardiac tumors, PsCT Postnatally found cardiac tumors, HM hypomelanotic macules, RH retinal hamartomas, CT cortical tubers, SENs subependymal nodules, MCD malformation of cortical development, NMI No Mutation Identified, N normal, na not applicable, abn abnormal, FD focal discharges, CS clonic seizure, FS focal seizure, IS infantile spasms, GVG Vigabatrin, LD language delay, ASD autism spectrum disorders.
  2. Time from A to B: Time from age at abnormal EEG to age at seizure onset